Moderna, Inc.
NASDAQ:MRNA
Overview | Financials
Company Name | Moderna, Inc. |
Symbol | MRNA |
Currency | USD |
Price | 42.14 |
Market Cap | 16,216,230,520 |
Dividend Yield | 0% |
52-week-range | 41.54 - 170.47 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Stephane Bancel |
Website | https://www.modernatx.com |
An error occurred while fetching data.
About Moderna, Inc.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD